Management of Infants with Congenital Adrenal Hyperplasia

Treatment of congenital adrenal hyperplasia (CAH) requires lifelong replacement of glucocorticoids with regular follow up to manageassociated morbidities. The current review focuses on follow-up and management of infants diagnosed with classical CAH pertinent toIndian context. Early initiation of oral hydrocortisone in divided doses is recommended after diagnosis in newborn period, infancy andchildhood. Fludrocortisone is recommended for all infants with classical CAH. All infants should be monitored as per protocol fordisease and treatment related complications. The role of prenatal steroids to pregnant women with previous history of CAH affectedinfant for prevention of virilization of female fetus is controversial.

Keywords

Adrenal crisis, Complication, Glucocorticoid, 17OHP, Mineralocorticoid

Citation

Dabas Aashima, Vats Pallavi, Sharma Rajni, Singh Preeti, Seth Anju, Jain Vandana, Batra Prerna, Gupta Neerja, Kumar Ravindra, Kabra Madhulika, Kapoor Seema, Yadav Sangeeta. Management of Infants with Congenital Adrenal Hyperplasia. Indian Pediatrics. 2020 Feb; 57(2): 159-164

URI

https://imsear.searo.who.int/handle/123456789/199480

Collections

Indian Pediatrics

Full item page